| 1 |
33512474 | CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1. | 2021 Apr 22 |
3 |
| 2 |
24457597 | Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress. | 2014 Jan 15 |
1 |
| 3 |
24686085 | Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity. | 2014 Jul |
1 |
| 4 |
24718698 | Dasatinib targets B-lineage cells but does not provide an effective therapy for myeloproliferative disease in c-Cbl RING finger mutant mice. | 2014 |
1 |
| 5 |
23400592 | Inhibition of SRC corrects GM-CSF hypersensitivity that underlies juvenile myelomonocytic leukemia. | 2013 Apr 15 |
1 |
| 6 |
23696637 | CBL linker region and RING finger mutations lead to enhanced granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling via elevated levels of JAK2 and LYN. | 2013 Jul 5 |
2 |
| 7 |
22787428 | Degradation of epidermal growth factor receptor mediates dasatinib-induced apoptosis in head and neck squamous cell carcinoma cells. | 2012 Jun |
5 |
| 8 |
18797457 | Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer. | 2008 Oct 7 |
1 |